What Research Shows About Semaglutide and Inflammation Clinical research increasingly demonstrates that GLP-1based therapies may influence inflammation independently of weight loss
"The goal of the Wegovy Pregnancy Registry is to help health care providers, patients and researchers better understand the safety of Wegovy and other weight-loss medications during pregnancy," the registry states
Excess weight increases the risk of type 2 diabetes, high blood pressure, heart disease, fatty liver disease, sleep apnea, joint pain, stroke, and some cancers
Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Because the goal isnt just to weigh less
While GLP-1 RAs have provided an important new weapon for those suffering from profound obesity, they unfortunately trigger the same counter-productive mechanisms as other weight-loss efforts, which rely on caloric restriction, resulting in muscle loss, which limits the fat loss and metabolic benefit
